173 related articles for article (PubMed ID: 34072782)
1. Tracking the Antibody Immunome in Sporadic Colorectal Cancer by Using Antigen Self-Assembled Protein Arrays.
González-González M; Sayagués JM; Muñoz-Bellvís L; Pedreira CE; de Campos MLR; García J; Alcázar JA; Braz PF; Galves BL; González LM; Bengoechea O; Abad MDM; Cruz JJ; Bellido L; Fonseca E; Díez P; Juanes-Velasco P; Landeira-Viñuela A; Lecrevisse Q; Montalvillo E; Góngora R; Blanco O; Sánchez-Santos JM; LaBaer J; Orfao A; Fuentes M
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072782
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated Expression of Three Genes in Colorectal Cancer Stratifies Patients into Three Risk Groups.
Rodriguez A; Corchete LA; Alcazar JA; Montero JC; Rodriguez M; Chinchilla-Tábora LM; Vidal Tocino R; Moyano C; Muñoz-Bravo S; Sayagués JM; Abad M
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077612
[TBL] [Abstract][Full Text] [Related]
3. Genomic profiling of sporadic liver metastatic colorectal cancer.
González-González M; Gutiérrez ML; Sayagués JM; Muñoz-Bellvís L; Orfao A
Semin Cancer Biol; 2021 Jun; 71():98-108. PubMed ID: 32485312
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of a novel gene expression profile classifier for the discrimination between metastatic and non-metastatic primary colorectal cancer tumors.
Gutiérrez ML; Corchete LA; Sarasquete ME; Del Mar Abad M; Bengoechea O; Fermiñán E; Anduaga MF; Del Carmen S; Iglesias M; Esteban C; Angoso M; Alcazar JA; García J; Orfao A; Muñoz-Bellvís L; Sayagués JM
Oncotarget; 2017 Dec; 8(64):107685-107700. PubMed ID: 29296198
[TBL] [Abstract][Full Text] [Related]
5. Combined assessment of the TNM stage and
Sayagués JM; Del Carmen S; Del Mar Abad M; Corchete LA; Bengoechea O; Anduaga MF; Baldeón MJ; Cruz JJ; Alcazar JA; Angoso M; González M; García J; Muñoz-Bellvis L; Orfao A; Sarasquete ME
Oncotarget; 2018 May; 9(35):24081-24096. PubMed ID: 29844874
[TBL] [Abstract][Full Text] [Related]
6. Identification of a characteristic copy number alteration profile by high-resolution single nucleotide polymorphism arrays associated with metastatic sporadic colorectal cancer.
González-González M; Fontanillo C; Abad MM; Gutiérrez ML; Mota I; Bengoechea O; Santos-Briz Á; Blanco O; Fonseca E; Ciudad J; Fuentes M; De Las Rivas J; Alcazar JA; García J; Muñoz-Bellvis L; Orfao A; Sayagués JM
Cancer; 2014 Jul; 120(13):1948-59. PubMed ID: 24668684
[TBL] [Abstract][Full Text] [Related]
7. Comparison of long-term outcomes between Lynch sydrome and sporadic colorectal cancer: a propensity score matching analysis.
Xu Y; Li C; Zheng CZ; Zhang YQ; Guo TA; Liu FQ; Xu Y
BMC Cancer; 2021 Jan; 21(1):45. PubMed ID: 33422027
[TBL] [Abstract][Full Text] [Related]
8. Lymphangiogenic and angiogenic microvessel density in human primary sporadic colorectal carcinoma.
Yan G; Zhou XY; Cai SJ; Zhang GH; Peng JJ; Du X
World J Gastroenterol; 2008 Jan; 14(1):101-7. PubMed ID: 18176970
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Molecular Profiling of Colorectal Cancer With Situs Inversus Totalis by Next-Generation Sequencing.
Li H; Gong L; Cheng H; Wang H; Zhang X; Rao C; Song Z; Wang D; Lou H; Lou F; Cao S; Pan H; Fang Y
Front Oncol; 2022; 12():813253. PubMed ID: 35530355
[TBL] [Abstract][Full Text] [Related]
10. Synchronous colorectal carcinoma: predisposing factors and characteristics.
Chin CC; Kuo YH; Chiang JM
Colorectal Dis; 2019 Apr; 21(4):432-440. PubMed ID: 30578740
[TBL] [Abstract][Full Text] [Related]
11. Alteration of tumor suppressor BMP5 in sporadic colorectal cancer: a genomic and transcriptomic profiling based study.
Chen E; Yang F; He H; Li Q; Zhang W; Xing J; Zhu Z; Jiang J; Wang H; Zhao X; Liu R; Lei L; Dong J; Pei Y; Yang Y; Pan J; Zhang P; Liu S; Du L; Zeng Y; Yang J
Mol Cancer; 2018 Dec; 17(1):176. PubMed ID: 30572883
[TBL] [Abstract][Full Text] [Related]
12. Genomic characterization of liver metastases from colorectal cancer patients.
Sayagués JM; Corchete LA; Gutiérrez ML; Sarasquete ME; Del Mar Abad M; Bengoechea O; Fermiñán E; Anduaga MF; Del Carmen S; Iglesias M; Esteban C; Angoso M; Alcazar JA; García J; Orfao A; Muñoz-Bellvis L
Oncotarget; 2016 Nov; 7(45):72908-72922. PubMed ID: 27662660
[TBL] [Abstract][Full Text] [Related]
13. Molecular evaluation of glutathione S transferase family genes in patients with sporadic colorectal cancer.
Rodrigues-Fleming GH; Fernandes GMM; Russo A; Biselli-Chicote PM; Netinho JG; Pavarino ÉC; Goloni-Bertollo EM
World J Gastroenterol; 2018 Oct; 24(39):4462-4471. PubMed ID: 30356976
[TBL] [Abstract][Full Text] [Related]
14. New Perspectives in Multiple Primary Colorectal Cancer: A Surgical Approach.
Brandariz L; Alegre C; Rueda D; Arriba M; Alonso L; Nutu A; Rodríguez Y; Pajares JA; Ferrero E; García-Borda J; Perea J
Digestion; 2016; 94(2):57-65. PubMed ID: 27490961
[TBL] [Abstract][Full Text] [Related]
15. Genetic heterogeneity in synchronous colorectal cancers impacts genotyping approaches and therapeutic strategies.
Jesinghaus M; Pfarr N; Kloor M; Endris V; Tavernar L; Muckenhuber A; von Knebel Doeberitz M; Penzel R; Weichert W; Stenzinger A
Genes Chromosomes Cancer; 2016 Mar; 55(3):268-77. PubMed ID: 26650777
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between mismatch repair proteins status and clinicopathological characteristics in sporadic colorectal cancer patients].
Xiao ZT; Zhang RX; Zhao Y; Peng JH; Lu SX; Zhang HZ; Ding PR; Wu XJ; Lu ZH; Li LR; Wan DS; Pan ZZ; Chen G
Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(16):1248-1251. PubMed ID: 28441855
[No Abstract] [Full Text] [Related]
17. Molecular analysis of MLH1 variants in Chinese sporadic colorectal cancer patients.
Peng HX; Xu X; Yang R; Chu YM; Yang DM; Xu Y; Zhou FL; Ma WZ; Zhang XJ; Guan M; Yang ZH; Jin ZD
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173243
[TBL] [Abstract][Full Text] [Related]
18.
Fernandes GM; Russo A; Proença MA; Gazola NF; Rodrigues GH; Biselli-Chicote PM; Silva AE; Netinho JG; Pavarino ÉC; Goloni-Bertollo EM
World J Gastroenterol; 2016 Dec; 22(45):9974-9983. PubMed ID: 28018104
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody profiling identifies predictive biomarkers of response to anti-PD1 therapy in cancer patients.
Tan Q; Wang D; Yang J; Xing P; Yang S; Li Y; Qin Y; He X; Liu Y; Zhou S; Duan H; Liang T; Wang H; Wang Y; Jiang S; Zhao F; Zhong Q; Zhou Y; Wang S; Dai J; Yao J; Wu D; Zhang Z; Sun Y; Han X; Yu X; Shi Y
Theranostics; 2020; 10(14):6399-6410. PubMed ID: 32483460
[No Abstract] [Full Text] [Related]
20. Common habitual behaviors and synchronous colorectal cancer risk: a retrospective case-control study.
Kuo YH; Hung HY; You JF; Chiang JM; Chin CC
Int J Colorectal Dis; 2019 Aug; 34(8):1421-1430. PubMed ID: 31278528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
